NCT03924973Completed
3 Year Follow up Study of the IDEA Population
Long-term Efficacy of Early Intervention With Early Start Denver Model (ESDM) on the Severity of Autism
Source: ClinicalTrials.gov · Last updated 6 Mar 2025
Brief summary (registry, in English)
The aim of this study is to assess the efficiency of early treatment for ASD children 5 years after initial treatment. The early treatment implemented was 12 hours per week of ESDM versus treatment as usual during 2 years. This was done as an RCT, called IDEA. Children will now be included in IDEA-2 SCOLA, a three year follow up study.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 93 (actual)
- First submitted
- 19 Apr 2019
- Start date
- 17 Apr 2019
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Hôpital le Vinatier
- Diseases
- Autism
- NCT number
- NCT03924973
What you commit to
- Study type: Interventional
- Participants enrolled: 93
- From 17 Apr 2019 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Impossibility of coming in for assessment
- Exclusion from IDEA
Who the study is looking for
- Inclusion in the initial IDEA trail
- Requiring less than 40 minutes travel to the assessment center
Age in the registry: 39 months to 60 months · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hopital Vinatier Coordinator of this site? Confirm its status | Bron | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.